MarketWatch
US · 1 hrs ago
✦ 78◉ Centre
Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug
78Quality
0Ratings
0Comments
AI Analysis
Quality 78/100
Partisan intensity 25/100
ObjectivePartisan
◉ Centre ✓ Fair headline
Eli Lilly's share price rose in premarket trading following positive results from a late-stage clinical trial of its new weight-loss medication.
Eli Lilly stock jumps after late-stage trial of next-generation weight-loss drug
Eli Lilly shares jumped in premarket trade on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!